Glipizide Tablet
Product Images NDC 51407-621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51407-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-621-10ol (51407 621 10ol)

51407-621-10ol (51407 621 10ol)
This is a description of a medication called glipizide in tablet form with a dosage of 10mg per tablet. The medication should be dispensed in a light-resistant container with a child-resistant closure and stored at room temperature. The manufacturer is ANI Pharmaceuticals Canada Inc. and it is marketed by GSMS, Incorporated. It is important to keep this medication out of the reach of children. It is also recommended to refer to the accompanying Prescribing Information for dosage instructions.*
FDA Label Image

Structure (Image 01)

FDA Label Image

Logo (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.